Multi-Analytes Analysis in Prostate Cancer: Overcoming Tumor Heterogeneity Challenges with Liquid Biopsy
Time: 6:00 pm
day: Day One Track A (2)
Details:
- Impact of tumor heterogeneity on drug development and patient selection
- Advantages of a multi-analyte biomarker approach in a phase 1 trial
- Opportunity, and challenges, of precision medicine for prostate cancer
